Medical specialists from China tagged as investigators in clinical trials studying Esophageal Neoplasms

Total 143 results

Bao fu Chen, professor
Seen in:
- Zhejiang, Linhai, Thaizhou Hospital
Trials:
- NCT02188615 (Principal Investigator)
Conditions:
- Squamous Cell Esophageal Carcinoma
Baoping Chang, MD, PhD
Seen in:
- Henan, Luoyang, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology
Trials:
- NCT02972372 (Sub-Investigator)
Conditions:
- Esophagus Cancer
Baosheng Li, Ph.D.
Seen in:
- Shandong, Jinan, Shandong Cancer Hospital and Institute
Trials:
- NCT01630174 (Principal Investigator)
Conditions:
- Esophageal Cancer
Bo Xu, Doctor
Seen in:
- Beijing, Beijing, Beijing Cancer Hospital
Trials:
- NCT00642239 (Principal Investigator)
Conditions:
- Esophageal Carcinoma
Changzhen Shang, MD
Seen in:
- Guangdong, Guangzhou, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Trials:
- NCT06036563 (Sub-Investigator)
Conditions:
- Breast Cancer;
- Gastric Cancer;
- Colorectal Cancer;
- Pancreas Cancer;
- Liver Cancer;
- Esophagus Cancer;
- Cancer Diagnosis;
- LungCancer
Changzheng Li
Seen in:
- Shandong, Jinan, Shandong Cancer Hospital
Trials:
- NCT04385550 (Principal Investigator)
- NCT06221748 (Principal Investigator)
Conditions:
Chao Zhou, MD
Seen in:
- Zhejiang, Taizhou, Taizhou Enze Medical Center(Group) Enze Hospital
Trials:
- NCT05817201 (Sub-Investigator)
Conditions:
Chenjie Xu, Ph.D
Seen in:
- Beijing, Beijing Friendship Hospital, Capital Medical University
Trials:
- NCT06278064 (Sub-Investigator)
Conditions:
- Gastric Cancer;
- Esophagus Cancer
Chuangxin Lu
Seen in:
- Beijing, Beijing, Beijing Cancer Hospital
Trials:
- NCT06238843 (Principal Investigator)
Conditions:
- Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Chuangzhen Chen, MD
Seen in:
- Guangdong, Shantou, Cancer Hospital, Shantou University Medical College
Trials:
- NCT02556762 (Principal Investigator)
- NCT03744819 (Principal Investigator)
- NCT05189028 (Principal Investigator)
- NCT06076135 (Principal Investigator)
Conditions:
Chun-Xiao Ma
Seen in:
- Henan, Zhengzhou, Henan Provincial People's Hospital
Trials:
- NCT03941626 (Principal Investigator)
Conditions:
- Glioma;
- Gastric Cancer;
- Hepatoma;
- Esophagus Cancer
Dan Zhou, MD
Seen in:
- Guangdong, Guangzhou, Guangdong Cardiovascular Institute,Guangdong General Hospital
- Henan, Luoyang, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology
Trials:
- NCT02972372 (Sub-Investigator)
- NCT02723643 (Sub-Investigator)
Conditions:
- Esophagus Cancer;
- Hypertension,Essential
Dazhi Xu, MD
Seen in:
- Shanghai, Fudan University Shanghai Cancer Center
Trials:
- NCT06121700 (Principal Investigator)
Conditions:
Deruo Liu, MD
Seen in:
- Beijing, Beijing, China-Japan Friendship Hospital
Trials:
- NCT02355249 (Principal Investigator)
Conditions:
- Esophageal Carcinoma
Diansan Su, Doctor
Seen in:
- Shanghai, Shanghai, Renji Hospital, School of Medicine, Shanghai Jiaotong University
Trials:
- NCT01979549 (Principal Investigator)
Conditions:
Feng Jin, Bachelor
Seen in:
- Guizhou, Guiyang, Cancer Hospital of Guizhou Medical University
Trials:
- NCT02937519 (Principal Investigator)
Conditions:
- Esophageal Neoplasms
Fenghua Wang, MD, PhD
Seen in:
- Guangdong, Guangzhou, Cancer center of Sun Yat-sen University
Trials:
- NCT05163483 (Sub-Investigator)
Conditions:
- Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
Fengxia Gan, PhD
Seen in:
- Guangdong, Guangzhou, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Trials:
- NCT06036563 (Sub-Investigator)
Conditions:
- Breast Cancer;
- Gastric Cancer;
- Colorectal Cancer;
- Pancreas Cancer;
- Liver Cancer;
- Esophagus Cancer;
- Cancer Diagnosis;
- LungCancer
FengYing Wang, Doctor
Seen in:
- Shanghai, Shanghai, Zhongshan Hospital of Fudan University
Trials:
- NCT00642239 (Principal Investigator)
Conditions:
- Esophageal Carcinoma
guo l xu
Seen in:
- Guangdong, Guangzhou, Department of Endoscopy and Laser,Sun Yat-Sen University,Cancer Center
Trials:
- NCT01043016 (Principal Investigator)
Conditions:
- Esophageal Cancer;
- Skin Cancer
Guoqiang Kong, MD
Seen in:
- Henan, Luoyang, The Clinical Medical College, The First Affiliated Hospital of Henan University of Science and Technology
- Henan, Luoyang, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology
Trials:
- NCT04648917 (Sub-Investigator)
- NCT02972372 (Sub-Investigator)
Conditions:
- Esophagus Cancer, Stage III;
- Esophagus Cancer
Haihua Yang, MD
Seen in:
- Zhejiang, Taizhou, Haihua Yang
- Zhejiang, Taizhou, Haihua, Yang
- Zhejiang, Taizhou, Taizhou Enze Medical Center(Group) Enze Hospital
Trials:
- NCT04813705 (Principal Investigator)
- NCT04363255 (Principal Investigator)
- NCT05817201 (Principal Investigator)
Conditions:
Haiping Jiang
Seen in:
- Beijing, Beijing, Beijing Cancer Hospital
- Hangzhou, The First Affiliated Hospital, College of Medicine, Zhejiang University
- Zhejiang, Hangzhou, The First Affiliated Hospital, Zhejiang University School of Medicine - PPDS
- Zhejiang, Hangzhou, The first Affiliated Hospital, Zhejiang University School of Medicine
Trials:
- NCT05152147 (Principal Investigator)
- NCT04381650 (Principal Investigator)
- NCT06238843 (Principal Investigator)
Conditions:
Hang Jiang, Bachelor
Seen in:
- Guizhou, Guiyang, Cancer Hospital of Guizhou Medical University
Trials:
- NCT02937519 (Sub-Investigator)
Conditions:
- Esophageal Neoplasms
Hongli Li, MD.PHD
Seen in:
- Tianjin, Tianjin, TianjinCIH
Trials:
- NCT03366883 (Sub-Investigator)
Conditions:
- Esophageal Cancer Stage III;
- Esophageal Cancer Stage IIB
Hongying Liao, Professor
Seen in:
- Guangdong, Guangzhou, The Sixth Affiliated Hospital of Sun Yat-sen University
Trials:
- NCT05174156 (Principal Investigator)
Conditions:
- Advanced Esophageal Cancer
Hui Li, MD
Seen in:
- Beijing, Beijing, Beijing Chao-Yang Hospital
- Beijing, Beijing, Beijing ChaoYang Hospital
- Jiangsu, Suzhou, The Second Affiliated Hospital of Soochow University
Trials:
- NCT02355249 (Principal Investigator)
- NCT02125240 (Principal Investigator)
- NCT05732077 (Principal Investigator)
Conditions:
Hui Liu, Ph.D
Seen in:
- Guangzhou, Sun Yat-sen University
Trials:
- NCT06019455 (Principal Investigator)
Conditions:
- Esophageal Cancer;
- Lung Cancer
Jiachun Sun, MD, PhD
Seen in:
- Henan, Luoyang, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology
Trials:
- NCT02972372 (Sub-Investigator)
Conditions:
- Esophagus Cancer
Jian Zhu, MD
Seen in:
- Zhejiang, Taizhou, Haihua Yang
Trials:
- NCT05817201 (Sub-Investigator)
Conditions:

Clinical Trials on Esophageal Neoplasms

University Hospital, Lille
Federation of Research in Surgery (FRENCH); French Eso-Gastric Tumors Working... and other collaborators

Completed

Outcomes After Esophageal Cancer Surgery (FREGAT I)

Esophageal Neoplasm | Esophageal Disease

France
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy

Stage IIIA Esophageal Adenocarcinoma | Stage IIIB Esophageal Adenocarcinoma | Stage IIIC Esophageal Adenocarcinoma | Stage IIB Esophageal Adenocarcinoma | Stage IB Esophageal Adenocarcinoma | Stage IIA Esophageal Adenocarcinoma

United States
University of Michigan Rogel Cancer Center
Genentech, Inc.

Terminated

Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

Loco-regional Esophageal Cancer
Universitaire Ziekenhuizen KU Leuven

Completed

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)

Belgium
Cancer Institute and Hospital, Chinese Academy...
Peking University Cancer Hospital & Institute

Recruiting

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy

Esophageal Neoplasm Metastatic | Esophageal Cancer Stage IVb

China
Emory University
Novartis

Completed

Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

Esophageal Cancer | Neoplasms, Esophageal

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Withdrawn

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

Stage IIB Esophageal Cancer AJCC v7 | Stage III Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7
National Cancer Institute (NCI)

Recruiting

Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer

Neoplasms | Esophageal Neoplasms | Esophagus Cancer | Esophagus Neoplasm | Neoplasms, Esophageal | Esophageal Cancer (EsC)

United States
CellSeed Inc.

Terminated

A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group

Superficial Esophageal Cancer

Japan
Academisch Medisch Centrum - Universiteit van Amsterdam...
UMC Utrecht

Completed

PDL-1 Targeting in Resectable Oesophageal Cancer (PERFECT)

Esophageal Cancer, Stage II | Esophageal Cancer Stage III

Netherlands

Medical specialists from China tagged as investigators in clinical trials studying Esophageal Neoplasms

Clinical Trials on Esophageal Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations